# Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

> **NCT00200200** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 73 (actual)

## Conditions studied

- Hepatic Metastases
- Colon Cancer
- Rectal Cancer

## Interventions

- **DRUG:** Bevacizumab HAI plus systemic chemotherapy
- **DRUG:** HAI plus systemic chemotherapy

## Key facts

- **NCT ID:** NCT00200200
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11-19
- **Primary completion:** 2025-03-13
- **Final completion:** 2025-03-13
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2025-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00200200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00200200, "Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00200200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*